59 related articles for article (PubMed ID: 16471325)
1. Effect of incadronate on proliferation of mesenchymal tumor cells with or without activated Ras mutation.
Kawashima H; Ogose A; Hotta T; Ito T; Endo N; Kawashima H; Tamura K; Nakano K
J Exp Clin Cancer Res; 2005 Dec; 24(4):617-24. PubMed ID: 16471325
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
[TBL] [Abstract][Full Text] [Related]
3. Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
Iguchi K; Nakano T; Usui S; Hirano K
Cancer Lett; 2006 Jun; 237(2):223-33. PubMed ID: 16019130
[TBL] [Abstract][Full Text] [Related]
4. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ
Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
[TBL] [Abstract][Full Text] [Related]
6. Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1/2-Cbfa1 signaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate.
Fujita T; Izumo N; Fukuyama R; Meguro T; Yasutomi C; Nakamuta H; Koida M
Jpn J Pharmacol; 2001 May; 86(1):86-96. PubMed ID: 11430477
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
Merrell MA; Wakchoure S; Lehenkari PP; Harris KW; Selander KS
Eur J Pharmacol; 2007 Sep; 570(1-3):27-37. PubMed ID: 17640631
[TBL] [Abstract][Full Text] [Related]
9. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
[TBL] [Abstract][Full Text] [Related]
10. High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.
Mather A; Chen XM; McGinn S; Field MJ; Sumual S; Mangiafico S; Zhang Y; Kelly DJ; Pollock CA
Int J Biochem Cell Biol; 2009 Mar; 41(3):561-9. PubMed ID: 18692592
[TBL] [Abstract][Full Text] [Related]
11. Incadronate induces cell detachment and apoptosis in prostatic PC-3 cells.
Matsunaga S; Iguchi K; Usui S; Hirano K
Anticancer Res; 2007; 27(2):927-32. PubMed ID: 17465222
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
Goffinet M; Thoulouzan M; Pradines A; Lajoie-Mazenc I; Weinbaum C; Faye JC; Séronie-Vivien S
BMC Cancer; 2006 Mar; 6():60. PubMed ID: 16539721
[TBL] [Abstract][Full Text] [Related]
13. Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells.
Adler V; Bowne W; Kamran I; Michl J; Friedman FK; Chin E; Zenilman M; Pincus MR
Cancer Chemother Pharmacol; 2008 Aug; 62(3):491-8. PubMed ID: 18066549
[TBL] [Abstract][Full Text] [Related]
14. The farnesyltransferase inhibitor, LB42708, inhibits growth and induces apoptosis irreversibly in H-ras and K-ras-transformed rat intestinal epithelial cells.
Kim HS; Kim JW; Gang J; Wen J; Koh SS; Koh JS; Chung HH; Song SY
Toxicol Appl Pharmacol; 2006 Sep; 215(3):317-29. PubMed ID: 16712893
[TBL] [Abstract][Full Text] [Related]
15. Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate.
Nakajima H; Magae J; Tsuruga M; Sakaguchi K; Fujiwara I; Mizuta M; Sawai K; Yamagishi H; Mizuta N
Cancer Lett; 2007 Aug; 253(1):89-96. PubMed ID: 17316980
[TBL] [Abstract][Full Text] [Related]
16. Nitrogen-containing bisphosphonate incadronate augments the inhibitory effect of farnesyl transferase inhibitor tipifarnib on the growth of fresh and cloned myeloma cells in vitro.
Ochiai N; Yamada N; Uchida R; Fuchida S; Okano A; Okamoto M; Ashihara E; Inaba T; Shimazaki C
Leuk Lymphoma; 2005 Nov; 46(11):1619-25. PubMed ID: 16236616
[TBL] [Abstract][Full Text] [Related]
17. Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells).
Asada S; Sasaki K; Tanaka N; Takeda K; Hayashi M; Umeda M
Mutat Res; 2005 Dec; 588(1):7-21. PubMed ID: 16260176
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status.
Ory B; Blanchard F; Battaglia S; Gouin F; Rédini F; Heymann D
Mol Pharmacol; 2007 Jan; 71(1):333-43. PubMed ID: 17050806
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents.
Singh US; Shankar R; Kumar A; Trivedi R; Chattopadhyay N; Shakya N; Palne S; Gupta S; Hajela K
Bioorg Med Chem; 2008 Sep; 16(18):8482-91. PubMed ID: 18752963
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
Koshimune R; Aoe M; Toyooka S; Hara F; Ouchida M; Tokumo M; Sano Y; Date H; Shimizu N
BMC Cancer; 2007 Jan; 7():8. PubMed ID: 17222343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
